bpc-157 delayed onset muscle soreness study Stable Gastric Pentadecapeptide BPC 157 as Therapy After Surgical Detachment of the Quadriceps from Its Attachments for Muscle-to-Bone Reattachment in Rats BPC-157 Peptide: Heal Muscles, Joints

96372: For therapeutic/diagnostic drugs (e.g., [Ketorolac] for pain)

Muscle Preservation Weight-loss interventions often cause muscle loss

Together, the two meetings will address 12 of the 19 peptides placed in Category 2 in 2023

these products tend to appeal to researchers exploring compounds that do not always fit neatly inside mainstream categories but still deserve targeted attention

As discussed in the CY 2026 OPPS/ASC proposed rule (90 FR 33476), hospitals and MRF users have indicated in inquiries to CMS that they are confused about our current requirements for encoding payer-specific negotiated charges, so we clarified our current policy in the proposed rule